Zobrazeno 1 - 10
of 27
pro vyhledávání: '"Ahmed El Bastawisy"'
Autor:
Osama Mohamed, Ahmed El Bastawisy, Nasr Allahlobi, Mona S. Abdellateif, Abdel Rahman N. Zekri, Sabry Shaarawy, Zeinab Korany, Marwa Mohanad, Abeer A. Bahnassy
Publikováno v:
Diagnostic Pathology, Vol 15, Iss 1, Pp 1-13 (2020)
Abstract Background CD68+ tumor-associated macrophages (TAM) play an important role in the progression of classical Hodgkin lymphoma (cHL). We assessed the role of CD20 and CD68 + TAM in a cohort of cHL patients from Egypt and correlated the number o
Externí odkaz:
https://doaj.org/article/a3a8a1500d66402986724280f29a6083
Autor:
Nada Ezzeldin, Dalia El-Lebedy, Amira Darwish, Ahmed El Bastawisy, Shereen Hamdy Abd Elaziz, Mirhane Mohamed Hassan, Amal Saad-Hussein
Publikováno v:
BMC Cancer, Vol 18, Iss 1, Pp 1-9 (2018)
Abstract Background Several studies have reported the role of CYP2A6 genetic polymorphisms in smoking and lung cancer risk with some contradictory results in different populations. The purpose of the current study is to assess the contribution of the
Externí odkaz:
https://doaj.org/article/bbc945358592448b8b87fe554592d4b2
Autor:
Danielle Bogan, Lucio Meile, Ahmed El Bastawisy, Hend F. Yousef, Abdel-Rahman N. Zekri, Abeer A. Bahnassy, Wael M. ElShamy
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
Abstract Background Breast cancer is the most globally diagnosed female cancer, with the triple negative breast cancer (TNBC) being the most aggressive subtype of the disease. In this study we aimed at comparing the effect of BRCA1-IRIS overexpressio
Externí odkaz:
https://doaj.org/article/8351b96d977143ac9b09eb554023cd6a
Autor:
Zeinab Korany, Nasr Allahlobi, Osama Mohamed, Sabry Shaarawy, Abdel-Rahman N. Zekri, Ahmed El Bastawisy, Mona S Abdellateif, Marwa Mohanad, Abeer A. Bahnassy
Publikováno v:
Diagnostic Pathology, Vol 15, Iss 1, Pp 1-13 (2020)
Diagnostic Pathology
Diagnostic Pathology
Background CD68+ tumor-associated macrophages (TAM) play an important role in the progression of classical Hodgkin lymphoma (cHL). We assessed the role of CD20 and CD68 + TAM in a cohort of cHL patients from Egypt and correlated the number of CD68 +
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0122f34ff5a6b2e076fba3f7d9c2e9d2
https://doaj.org/article/a3a8a1500d66402986724280f29a6083
https://doaj.org/article/a3a8a1500d66402986724280f29a6083
Publikováno v:
Journal of the Egyptian National Cancer InstituteReferences. 34(1)
Background Programmed death ligand-1 (PD-L1), anaplastic lymphoma kinase (ALK), and c-ros oncogene1 (ROS1) expression may influence the prognosis of non-small cell lung carcinoma (NSCLC). We aimed to investigate the prognostic and predictive signific
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::918226a4fe02fd0346118a02cfe5daf0
https://pubmed.ncbi.nlm.nih.gov/35644823
https://pubmed.ncbi.nlm.nih.gov/35644823
Autor:
Raghda Shehab El-Din, Nagwa Ali Sabri, Chahd.A. Abdel-Rahman, Abeer A. Bahnasy, Ahmed El Bastawisy
Publikováno v:
Cancer Genetics. :83-92
Malignant Pleural Mesothelioma (MPM) is a lethal cancer with few therapeutic options. Patients with MPM have a poor prognosis, with estimated 1 year median survival and currently no treatment is curative. The BRCA associated protein 1 (BAP1) has the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::eaf25ff7d529aae3f3da1514d5bef5ea
https://doi.org/10.1016/j.cancergen.2018.10.001
https://doi.org/10.1016/j.cancergen.2018.10.001
Autor:
Sofia D. Merajver, Saad Eissa, Ahmed El Bastawisy, Shahinaz M. Gadalla, Amel Mezlini, Catherine Schairer, Sandra M. Swain, Abdellatif Benider, Ibrahim AbdelBar Seif Eldein, Maha Yehia, Ali Tahri, H. Rais, Linda Morris Brown, Wided Ben Ayoub, Rabab Gaafar, Ruth M. Pfeiffer, Mouna Khouchani, Mehdi Karkouri, Dalia Aboulazm, Amr S. Soliman, Farhat Ben Ayed, Ahmed Hablas
Publikováno v:
Breast cancer research and treatment. 184(2)
Studies of the etiology of inflammatory breast cancer (IBC), a rare but aggressive breast cancer, have been hampered by limited risk factor information. We extend previous studies by evaluating a broader range of risk factors. Between 2009 and 2015,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::af711ed51172dda575e211626188845f
https://pubmed.ncbi.nlm.nih.gov/32876910
https://pubmed.ncbi.nlm.nih.gov/32876910
Autor:
Wael M. ElShamy, Abeer A. Bahnassy, Hend F. Yousef, Lucio Meile, Ahmed El Bastawisy, Abdel-Rahman N. Zekri, Danielle Bogan
Publikováno v:
BMC Cancer, Vol 17, Iss 1, Pp 1-10 (2017)
BMC Cancer
BMC Cancer
Background Breast cancer is the most globally diagnosed female cancer, with the triple negative breast cancer (TNBC) being the most aggressive subtype of the disease. In this study we aimed at comparing the effect of BRCA1-IRIS overexpression on the
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e1fe6f325f1c5bbc366be147d88fcce3
http://link.springer.com/article/10.1186/s12885-017-3283-8
http://link.springer.com/article/10.1186/s12885-017-3283-8
Publikováno v:
Journal of Cancer Therapy. :443-451
Background: malignant pleural mesothelioma (MPM) is characterized by long latency period between exposure to asbestos and development of the disease so we hypothesize that MPM in the young has different characteristics. Patients and Methods: This is
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4bac7eceaa95f65eac47e470eb0d06ec
https://doi.org/10.4236/jct.2017.85038
https://doi.org/10.4236/jct.2017.85038
Autor:
Hend F. Yousef, Abdel-Rahman N. Zekri, Lisa M. Sullivan, Abeer A. Bahnassy, Hillary B. Sims, Abhilasha Sinha, Ahmed El Bastawisy, Wael M. ElShaym, Bibbin T. Paul
Publikováno v:
Oncotarget
// Abhilasha Sinha 1, * , Bibbin T. Paul 2, * , Lisa M. Sullivan 3 , Hillary Sims 3 , Ahmed El Bastawisy 4 , Hend F. Yousef 5 , Abdel-Rahman N. Zekri 6 , Abeer A. Bahnassy 7 , Wael M. ElShamy 1, 3 1 Cancer Institute, University of Mississippi Medical
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5c8954d8cc6d90ed2f49f72de1a8f4
http://europepmc.org/articles/PMC5354646
http://europepmc.org/articles/PMC5354646